Australia's Next Science jumps on solid sales forecast

Next Science

29/06/2023 03:24

** Shares of Next Science  NXS.AX  jump as much as 27.1% to
A$0.610, set for best day since May 26, if gains hold
    ** Medical technology co says unaudited product sales for Q2
are expected to be above $5.6 mln vs $4.4 mln in previous
quarter
    ** Says, 1H23 is on track to substantially exceed product
sales in 1H22 and 2H22
    ** Adds, expected result due to the increased investment in
sales and marketing
    ** NXS stock at its highest level since June 5
    ** Stock down ~30% YTD as of last close
 

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))